Reagents

Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

10058-F4

Reference: A1169-50

€0.00 (tax incl.)

C-Myc-Max dimerization inhibitor

Firefly Luciferase mRNA (ARCA, 5mCTP, ψUTP)

Reference: R1005-1

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

AG-18

Reference: A1173-5

€0.00 (tax incl.)

EGFR/PDGFR inhibitor

Sodium 11(Z)-Vaccenate, g

Reference: 42-1812

€0.00 (tax incl.)

Firefly Luciferase mRNA (ARCA, 5mCTP, ψUTP)

Reference: R1005-5

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA, 5mCTP and ΨUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

AG-18

Reference: A1173-5.1

€0.00 (tax incl.)

EGFR/PDGFR inhibitor

Sodium Ricinoleate, g

Reference: 42-1832

€0.00 (tax incl.)

SpCas9 mRNA (ARCA, 5mCTP, ψUTP)

Reference: R1006-.1

€0.00 (tax incl.)

Used with guideRNA for site-specific DNA cleavage in genome editing

AG-18

Reference: A1173-25

€0.00 (tax incl.)

EGFR/PDGFR inhibitor

Sodium 11(Z)-Vaccenate, 100 mg

Reference: 42-1812-9

€0.00 (tax incl.)

SpCas9 mRNA (ARCA, 5mCTP, ψUTP)

Reference: R1006-1

€0.00 (tax incl.)

Used with guideRNA for site-specific DNA cleavage in genome editing

AG-18

Reference: A1173-100

€0.00 (tax incl.)

EGFR/PDGFR inhibitor

Sodium Ricinoleate, 100 mg

Reference: 42-1832-9

€0.00 (tax incl.)

SpCas9 mRNA (ARCA, 5mCTP, ψUTP)

Reference: R1006-5

€0.00 (tax incl.)

Used with guideRNA for site-specific DNA cleavage in genome editing

AMG-517

Reference: A1174-5

€0.00 (tax incl.)

TRPV1 antagonist,potent and highly selective

Linoleyl methane sulfonate, g

Reference: 44-1802

€0.00 (tax incl.)

ARCA EGFP mRNA (5-moUTP)

Reference: R1007-.1

€0.00 (tax incl.)

New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.

AMG-517

Reference: A1174-5.1

€0.00 (tax incl.)

TRPV1 antagonist,potent and highly selective

CLA 10(E),12(Z) Ethyl Ester 90%, g

Reference: 30-1826-90-0

€0.00 (tax incl.)

ARCA EGFP mRNA (5-moUTP)

Reference: R1007-1

€0.00 (tax incl.)

New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.

AMG-517

Reference: A1174-25

€0.00 (tax incl.)

TRPV1 antagonist,potent and highly selective

CLA 10(E),12(Z) Ethyl Ester 90%, 1g

Reference: 30-1826-90-13

€0.00 (tax incl.)

ARCA EGFP mRNA (5-moUTP)

Reference: R1007-5

€0.00 (tax incl.)

New modification with better performance --- direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control to study transfection and expression in mammalian cells.

AMG-517

Reference: A1174-100

€0.00 (tax incl.)

TRPV1 antagonist,potent and highly selective

1,2-Arachidin-3-Stearin, 25 mg

Reference: 34-2018-7

€0.00 (tax incl.)

Synonyms: 1,2-Diarachidate-3-Stearate-Glycerol

ARCA Cy3 EGFP mRNA (5-moUTP)

Reference: R1008-.1

€0.00 (tax incl.)

5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.

BMS-754807

Reference: A1185-5

€0.00 (tax incl.)

IGF-1R/InsR inhibitor,potent and selective

1-Stearoyl-2-Docosahexaenoyl-sn-Glycero-3-Phosphatidylcholine, 25 mg

Reference: 37-1822-7

€0.00 (tax incl.)

Synonyms: (18:0/22:6) PC

ARCA Cy3 EGFP mRNA (5-moUTP)

Reference: R1008-1

€0.00 (tax incl.)

5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.

BMS-754807

Reference: A1185-5.1

€0.00 (tax incl.)

IGF-1R/InsR inhibitor,potent and selective

Trianoic acid, g

Reference: 10-0300

€0.00 (tax incl.)

Synonyms: Propionic acid; Propanoic acid

ARCA Cy3 EGFP mRNA (5-moUTP)

Reference: R1008-5

€0.00 (tax incl.)

5-moUTP-modified mRNA with better performance, Cy3 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.

BMS-754807

Reference: A1185-25

€0.00 (tax incl.)

IGF-1R/InsR inhibitor,potent and selective

Trianoic acid, 1 g

Reference: 10-0300-13

€0.00 (tax incl.)

Synonyms: Propionic acid; Propanoic acid

ARCA Cy5 EGFP mRNA (5-moUTP)

Reference: R1009-.1

€0.00 (tax incl.)

5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.

BMS-754807

Reference: A1185-100

€0.00 (tax incl.)

IGF-1R/InsR inhibitor,potent and selective

Trianoic acid, 10 g

Reference: 10-0300-17

€0.00 (tax incl.)

Synonyms: Propionic acid; Propanoic acid

ARCA Cy5 EGFP mRNA (5-moUTP)

Reference: R1009-1

€0.00 (tax incl.)

5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.

AMG-208

Reference: A1186-5

€0.00 (tax incl.)

C-Met inhibitor,potent and highly selective

Trianoic acid, 100 mg

Reference: 10-0300-9

€0.00 (tax incl.)

Synonyms: Propionic acid; Propanoic acid

ARCA Cy5 EGFP mRNA (5-moUTP)

Reference: R1009-5

€0.00 (tax incl.)

5-moUTP-modified mRNA with better performance, Cy5 tag, direct-detection reporter mRNA that suppresses RNA-mediated innate immune activation, used as control and tool for determining mRNA delivery and localization.

AMG-208

Reference: A1186-5.1

€0.00 (tax incl.)

C-Met inhibitor,potent and highly selective

Tetranoic acid, g

Reference: 10-0400

€0.00 (tax incl.)

Synonyms: Butyric acid; Butanoic acid

EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)

Reference: R1010-.1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

AMG-208

Reference: A1186-25

€0.00 (tax incl.)

C-Met inhibitor,potent and highly selective

Tetranoic acid, 1 g

Reference: 10-0400-13

€0.00 (tax incl.)

Synonyms: Butyric acid; Butanoic acid

EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)

Reference: R1010-1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

AMG-208

Reference: A1186-100

€0.00 (tax incl.)

C-Met inhibitor,potent and highly selective

Tetranoic acid, 10 g

Reference: 10-0400-17

€0.00 (tax incl.)

Synonyms: Butyric acid; Butanoic acid

EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP)

Reference: R1010-5

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

SGX-523

Reference: A1196-S

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

Tetranoic acid, 100 mg

Reference: 10-0400-9

€0.00 (tax incl.)

Synonyms: Butyric acid; Butanoic acid

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Reference: R1011-.1

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

SGX-523

Reference: A1196-5

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

Pentanoic acid, g

Reference: 10-0500

€0.00 (tax incl.)

Synonyms: Valeric acid; 1-Butanecarboxylic acid; Pentanoic acid

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Reference: R1011-1

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

SGX-523

Reference: A1196-5.1

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

Pentanoic acid, 1 g

Reference: 10-0500-13

€0.00 (tax incl.)

Synonyms: Valeric acid; 1-Butanecarboxylic acid; Pentanoic acid

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Reference: R1011-5

€0.00 (tax incl.)

EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation

SGX-523

Reference: A1196-25

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

Pentanoic acid, 10 g

Reference: 10-0500-17

€0.00 (tax incl.)

Synonyms: Valeric acid; 1-Butanecarboxylic acid; Pentanoic acid

Firefly Luciferase mRNA (ARCA, 5-moUTP)

Reference: R1012-.1

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

SGX-523

Reference: A1196-100

€0.00 (tax incl.)

MET inibitor, highly selective, ATP-competitive

Pentanoic acid, 100 mg

Reference: 10-0500-9

€0.00 (tax incl.)

Synonyms: Valeric acid; 1-Butanecarboxylic acid; Pentanoic acid

Firefly Luciferase mRNA (ARCA, 5-moUTP)

Reference: R1012-1

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

Levetiracetam

Reference: A1198-50

€0.00 (tax incl.)

Antiepileptic drug

Hexanoic acid, g

Reference: 10-0600

€0.00 (tax incl.)

Synonyms: Caproic acid

Firefly Luciferase mRNA (ARCA, 5-moUTP)

Reference: R1012-5

€0.00 (tax incl.)

Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.

Levetiracetam

Reference: A1198-5.1

€0.00 (tax incl.)

Antiepileptic drug

Hexanoic acid, 1 g

Reference: 10-0600-13

€0.00 (tax incl.)

Synonyms: Caproic acid

EZ Cap™ Firefly Luciferase mRNA (5-moUTP)

Reference: R1013-.1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Levetiracetam

Reference: A1198-100

€0.00 (tax incl.)

Antiepileptic drug

Hexanoic acid, 10 g

Reference: 10-0600-17

€0.00 (tax incl.)

Synonyms: Caproic acid

EZ Cap™ Firefly Luciferase mRNA (5-moUTP)

Reference: R1013-1

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.

Daptomycin

Reference: A1206-5.1

€0.00 (tax incl.)

Calcium-dependent antibiotic

Hexanoic acid, 100 mg

Reference: 10-0600-9

€0.00 (tax incl.)

Synonyms: Caproic acid

EZ Cap™ Firefly Luciferase mRNA (5-moUTP)

Reference: R1013-5

€0.00 (tax incl.)

Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.